Cargando…
Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Institut Pasteur. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133820/ https://www.ncbi.nlm.nih.gov/pubmed/34022374 http://dx.doi.org/10.1016/j.micinf.2021.104840 |
_version_ | 1783695126355247104 |
---|---|
author | Lan, Qiaoshuai Pu, Jing Cai, Yanxing Zhou, Jie Wang, Lijue Jiao, Fanke Xu, Wei Wang, Qian Xia, Shuai Lu, Lu Jiang, Shibo |
author_facet | Lan, Qiaoshuai Pu, Jing Cai, Yanxing Zhou, Jie Wang, Lijue Jiao, Fanke Xu, Wei Wang, Qian Xia, Shuai Lu, Lu Jiang, Shibo |
author_sort | Lan, Qiaoshuai |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8133820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Institut Pasteur. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81338202021-05-20 Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection Lan, Qiaoshuai Pu, Jing Cai, Yanxing Zhou, Jie Wang, Lijue Jiao, Fanke Xu, Wei Wang, Qian Xia, Shuai Lu, Lu Jiang, Shibo Microbes Infect Letter to the Editor Institut Pasteur. Published by Elsevier Masson SAS. 2021 2021-05-20 /pmc/articles/PMC8133820/ /pubmed/34022374 http://dx.doi.org/10.1016/j.micinf.2021.104840 Text en © 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Lan, Qiaoshuai Pu, Jing Cai, Yanxing Zhou, Jie Wang, Lijue Jiao, Fanke Xu, Wei Wang, Qian Xia, Shuai Lu, Lu Jiang, Shibo Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection |
title | Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection |
title_full | Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection |
title_fullStr | Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection |
title_full_unstemmed | Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection |
title_short | Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection |
title_sort | lipopeptide-based pan-cov fusion inhibitors potently inhibit hiv-1 infection |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133820/ https://www.ncbi.nlm.nih.gov/pubmed/34022374 http://dx.doi.org/10.1016/j.micinf.2021.104840 |
work_keys_str_mv | AT lanqiaoshuai lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT pujing lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT caiyanxing lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT zhoujie lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT wanglijue lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT jiaofanke lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT xuwei lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT wangqian lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT xiashuai lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT lulu lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection AT jiangshibo lipopeptidebasedpancovfusioninhibitorspotentlyinhibithiv1infection |